🇺🇸 FDA
Patent

US 10092580

Controlled-release otic structure modulating and innate immune system modulating compositions and methods for the treatment of otic disorders

granted A61KA61K31/5513A61K31/66

Quick answer

US patent 10092580 (Controlled-release otic structure modulating and innate immune system modulating compositions and methods for the treatment of otic disorders) held by The Regents of the University of California expires Mon Oct 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Oct 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K31/5513, A61K31/66, A61K31/663, A61K38/1748